Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Eltrombopag 50 mg tablets vs Revolade 50 mg tablets in healthy Thai volunteers under fasting
TCTR20250317001Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of eltrombopag (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
eltrombopag
Beyond the preview
Go deeper on TCTR20250317001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250317001.